Health ❯ Healthcare ❯ Regulatory Agencies

FDA

Drug Approval Process Recalls Vaccine Approval Process Drug Recalls Leadership Changes Drug Approval Drug Warnings Drug Approval Processes Product Recalls Drug Safety

HHS Names Permanent Heads for FDA Drug, Biologics and Tobacco Centers

The appointments are meant to steady the agency after heavy turnover, with a new deputy to centralize technology and AI policy.

Company Recalls Three Lots of Multi‑Dose Epinephrine Vials Over Contamination Concerns

FDA Works With Manufacturers to Expand Supply of Estradiol Menopause Patches

FDA Approves Zanvastro as First Treatment for Alexander Disease

FDA Approves Lisraya as First Oral Treatment for Adult Dermatomyositis

FDA Approves Moderna’s mFlusiva, First mRNA Flu Vaccine

Nearly 12 Million Rohto Eye Drop Cartons Recalled Over Sterility Concerns

More Than 2.5 Million Lupin Eye Drop Bottles Recalled Nationwide

Nationwide Recall of 25 mg Chlorthalidone Covers 11,460 Bottles

FDA Approves First Generic Single‑Dose Flu Drug

More Than 370,000 Duloxetine Bottles Recalled Over Nitrosamine Contamination

FDA Launches Retrospective Safety Study of Mifepristone

Pharmacal Recalls One Lot of MG217 Eczema Cream Over Staph Contamination

Reports Say Trump Signs Off on Plan to Remove FDA Chief Marty Makary

FDA Proposes Blocking Bulk Compounding of GLP-1 Drugs by Outsourcing Facilities

FDA Clears Vepdegestrant, First PROTAC Cancer Drug, for ESR1‑Mutated Breast Cancer

FDA Launches First Real-Time Clinical Trial Pilot With AstraZeneca and Amgen

FDA Elevates Nationwide Cough-Drop Recall to Class II

FDA Flags Recall of 3.1 Million Store-Brand Eye Drops Over Sterility Concerns

3.1 Million Bottles of Store-Brand Eye Drops Recalled for Sterility Concerns